Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion type Assertion NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_head.
- NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion description "[Also, 34% (12/35) of invasive lobular carcinomas showed chromosome 17 aneuploidy; approximately one-third of these cases were HER2 2+ (33%) and HER2 3+ (37%) that were not amplified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_provenance.
- NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion evidence source_evidence_literature NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_provenance.
- NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion SIO_000772 25337277 NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_provenance.
- NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion wasDerivedFrom befree-2016 NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_provenance.
- NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_assertion wasGeneratedBy ECO_0000203 NP1231622.RApNbxemeo0DGQ2EzVfSG-jEjSrYrRa_EQ8Hp5uOUPHno130_provenance.